{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,18]],"date-time":"2026-05-18T06:08:02Z","timestamp":1779084482477,"version":"3.51.4"},"reference-count":25,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Bull Exp Biol Med"],"published-print":{"date-parts":[[2026,2]]},"DOI":"10.1007\/s10517-026-06665-2","type":"journal-article","created":{"date-parts":[[2026,4,24]],"date-time":"2026-04-24T02:41:36Z","timestamp":1776998496000},"page":"499-508","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Variability of the Immunosuppressive Properties of Glioma Cell Lines"],"prefix":"10.1007","volume":"180","author":[{"given":"I. V.","family":"Kholodenko","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R. Yu.","family":"Saryglar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A. Y.","family":"Lupatov","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"K. V.","family":"Kovalskaya","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"O. A.","family":"Bystrykh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A. V.","family":"Kuprin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"K. N.","family":"Yarygin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2026,4,24]]},"reference":[{"issue":"5","key":"6665_CR1","doi-asserted-by":"publisher","first-page":"459","DOI":"10.1016\/S1470-2045(09)70025-7","volume":"10","author":"R Stupp","year":"2009","unstructured":"Stupp R, Hegi ME, Mason WP, et al. Effects of radiotherapy with concomitant and adjuvant temozolomide versus radiotherapy alone on survival in glioblastoma in a randomised phase III study: 5-year analysis of the EORTCNCIC trial. Lancet Oncol. 2009;10(5):459-66. https:\/\/doi.org\/10.1016\/S1470-2045(09)70025-7","journal-title":"Lancet Oncol."},{"issue":"2","key":"6665_CR2","doi-asserted-by":"publisher","first-page":"359","DOI":"10.1007\/s11060-011-0749-4","volume":"107","author":"DR Johnson","year":"2012","unstructured":"Johnson DR, O\u2019Neill BP. Glioblastoma survival in the United States before and during the temozolomide era. J Neurooncol. 2012;107(2):359-64. https:\/\/doi.org\/10.1007\/s11060-011-0749-4","journal-title":"J Neurooncol."},{"issue":"2","key":"6665_CR3","doi-asserted-by":"publisher","first-page":"190","DOI":"10.3171\/jns.2001.95.2.0190","volume":"95","author":"M Lacroix","year":"2001","unstructured":"Lacroix M, Abi-Said D, Fourney DR, et al. A multivariate analysis of 416 patients with glioblastoma multiforme: prognosis, extent of resection, and survival. J Neurosurg. 2001;95(2):190-8. https:\/\/doi.org\/10.3171\/jns.2001.95.2.0190","journal-title":"J Neurosurg."},{"issue":"5","key":"6665_CR4","doi-asserted-by":"publisher","first-page":"851","DOI":"10.3171\/2012.8.JNS12234","volume":"117","author":"D Orringer","year":"2012","unstructured":"Orringer D, Lau D, Khatri S, et al. Extent of resection in patients with glioblastoma: Limiting factors, perception of resectability, and effect on survival. J Neurosurg. 2012;117(5):851-9. https:\/\/doi.org\/10.3171\/2012.8.JNS12234","journal-title":"J Neurosurg."},{"issue":"12","key":"6665_CR5","doi-asserted-by":"publisher","first-page":"1354","DOI":"10.1038\/s41423-024-01226-x","volume":"21","author":"Y Liu","year":"2024","unstructured":"Liu Y, Zhou F, Ali H, et al. Immunotherapy for glioblastoma: Current state, challenges, and future perspectives. Cell Mol Immunol. 2024;21(12):1354-75. https:\/\/doi.org\/10.1038\/s41423-024-01226-x","journal-title":"Cell Mol Immunol."},{"issue":"20","key":"6665_CR6","doi-asserted-by":"publisher","first-page":"15037","DOI":"10.3390\/ijms242015037","volume":"24","author":"E Agosti","year":"2023","unstructured":"Agosti E, Zeppieri M, De Maria L, et al. Glioblastoma immunotherapy: A systematic review of the present strategies and prospects for advancements. Int J Mol Sci. 2023;24(20):15037. https:\/\/doi.org\/10.3390\/ijms242015037","journal-title":"Int J Mol Sci."},{"key":"6665_CR7","doi-asserted-by":"publisher","first-page":"1510549","DOI":"10.3389\/fimmu.2025.1510549","volume":"16","author":"L Zhu","year":"2025","unstructured":"Zhu L, Zhang L, Han S, et al. Research progress on the role of dendritic cells in glioma during 1992-2024: A bibliometric analysis. Front Immunol. 2025;16:1510549. https:\/\/doi.org\/10.3389\/fimmu.2025.1510549","journal-title":"Front Immunol."},{"issue":"2","key":"6665_CR8","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1007\/s11882-002-0001-6","volume":"2","author":"T Jakob","year":"2002","unstructured":"Jakob T, Traidl-Hoffmann C, Behrendt H. Dendritic cells \u2013 the link between innate and adaptive immunity in allergy. Curr Allergy Asthma Rep. 2002;2(2):93-5. https:\/\/doi.org\/10.1007\/s11882-002-0001-6","journal-title":"Curr Allergy Asthma Rep."},{"issue":"1","key":"6665_CR9","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1038\/s41698-024-00717-4","volume":"8","author":"A Sarantopoulos","year":"2024","unstructured":"Sarantopoulos A, Ene C, Aquilanti E. Therapeutic approaches to modulate the immune microenvironment in gliomas. NPJ Precis Oncol. 2024;8(1):241. https:\/\/doi.org\/10.1038\/s41698-024-00717-4","journal-title":"NPJ Precis Oncol."},{"issue":"5","key":"6665_CR10","doi-asserted-by":"publisher","first-page":"555","DOI":"10.1134\/s0006297908050088","volume":"73","author":"S Rakoff-Nahoum","year":"2008","unstructured":"Rakoff-Nahoum S, Medzhitov R. Role of toll-like receptors in tissue repair and tumorigenesis. Biochemistry (Moscow). 2008;73(5):555-61. https:\/\/doi.org\/10.1134\/s0006297908050088","journal-title":"Biochemistry (Moscow)."},{"key":"6665_CR11","doi-asserted-by":"publisher","first-page":"205031212110690","DOI":"10.1177\/20503121211069012","volume":"10","author":"B Mirlekar","year":"2022","unstructured":"Mirlekar B. Tumor promoting roles of IL10, TGF-\u03b2, IL4, and IL35: Its implications in cancer immunotherapy. SAGE Open Med. 2022;10:20503121211069012. https:\/\/doi.org\/10.1177\/20503121211069012","journal-title":"SAGE Open Med."},{"issue":"3","key":"6665_CR12","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1038\/85438","volume":"7","author":"J Wolfers","year":"2001","unstructured":"Wolfers J, Lozier A, Raposo G, et al. Tumor-derived exosomes are a source of shared tumor rejection antigens for CTL cross-priming. Nat Med. 2001;7(3):297-303. https:\/\/doi.org\/10.1038\/85438","journal-title":"Nat Med."},{"issue":"1","key":"6665_CR13","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1186\/s13045-021-01102-5","volume":"14","author":"XC Ding","year":"2021","unstructured":"Ding XC, Wang LL, Zhang XD, et al. The relationship between expression of PD-L1 and HIF-1\u03b1 in glioma cells under hypoxia. J Hematol Oncol. 2021;14(1):92. https:\/\/doi.org\/10.1186\/s13045-021-01102-5","journal-title":"J Hematol Oncol."},{"issue":"6","key":"6665_CR14","doi-asserted-by":"publisher","first-page":"827","DOI":"10.1007\/s00262-011-1143-y","volume":"61","author":"I Poschke","year":"2012","unstructured":"Poschke I, Mao Y, Adamson L, et al. Myeloid-derived suppressor cells impair the quality of dendritic cell vaccines. Cancer Immunol Immunother. 2012;61(6):827-38. https:\/\/doi.org\/10.1007\/s00262-011-1143-y","journal-title":"Cancer Immunol Immunother."},{"issue":"12","key":"6665_CR15","doi-asserted-by":"publisher","first-page":"3251","DOI":"10.3390\/cancers15123251","volume":"15","author":"L Gatto","year":"2023","unstructured":"Gatto L, Di Nunno V, Tosoni A, et al. DCVax-L vaccination in patients with glioblastoma: Real promise or negative trial? The debate is open. Cancers (Basel). 2023;15(12):3251. https:\/\/doi.org\/10.3390\/cancers15123251","journal-title":"Cancers (Basel)."},{"issue":"1","key":"6665_CR16","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1038\/s41698-024-00709-4","volume":"8","author":"NB Mercado","year":"2024","unstructured":"Mercado NB, Real JN, Kaiserman J, et al. Clinical implications of cytomegalovirus in glioblastoma progression and therapy. NPJ Precis Oncol. 2024;8(1):213. https:\/\/doi.org\/10.1038\/s41698-024-00709-4","journal-title":"NPJ Precis Oncol."},{"issue":"1","key":"6665_CR17","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1001\/jamaoncol.2022.5370","volume":"9","author":"LM Liau","year":"2023","unstructured":"Liau LM, Ashkan K, Brem S, et al. Association of autologous tumor lysate-loaded dendritic cell vaccination with extension of survival among patients with newly diagnosed and recurrent glioblastoma: A Phase 3 Prospective Externally Controlled Cohort Trial. JAMA Oncol. 2023;9(1):112-21. https:\/\/doi.org\/10.1001\/jamaoncol.2022.5370","journal-title":"JAMA Oncol."},{"issue":"6","key":"6665_CR18","doi-asserted-by":"publisher","first-page":"7207","DOI":"10.1002\/cam4.5511","volume":"12","author":"J Zhou","year":"2023","unstructured":"Zhou J, Li L, Jia M, et al. Dendritic cell vaccines improve the glioma microenvironment: Influence, challenges, and future directions. Cancer Med. 2023;12(6):7207-21. https:\/\/doi.org\/10.1002\/cam4.5511","journal-title":"Cancer Med."},{"key":"6665_CR19","doi-asserted-by":"publisher","first-page":"1259562","DOI":"10.3389\/fimmu.2023.1259562","volume":"14","author":"Y Zheng","year":"2023","unstructured":"Zheng Y, Ma X, Feng S, et al. Dendritic cell vaccine of gliomas: challenges from bench to bed. Front Immunol. 2023;14:1259562. https:\/\/doi.org\/10.3389\/fimmu.2023.1259562","journal-title":"Front Immunol."},{"issue":"1","key":"6665_CR20","doi-asserted-by":"publisher","first-page":"122","DOI":"10.1007\/s10517-024-06294-7","volume":"178","author":"IV Kholodenko","year":"2024","unstructured":"Kholodenko IV, Lupatov AY, Kim YS, et al. Mesenchymal properties of glioma cell lines. Bull Exp Biol Med. 2024;178(1):122-9. https:\/\/doi.org\/10.1007\/s10517-024-06294-7","journal-title":"Bull Exp Biol Med."},{"issue":"1","key":"6665_CR21","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1186\/s13046-017-0552-y","volume":"36","author":"S Han","year":"2017","unstructured":"Han S, Wang C, Qin X, et al. LPS alters the immunophenotype of glioma and glioma stem-like cells and induces in vivo antitumor immunity via TLR4. J Exp Clin Cancer Res. 2017;36(1):83. https:\/\/doi.org\/10.1186\/s13046-017- 0552-y","journal-title":"J Exp Clin Cancer Res."},{"issue":"32","key":"6665_CR22","doi-asserted-by":"publisher","first-page":"53495","DOI":"10.18632\/oncotarget.18586","volume":"8","author":"F Che","year":"2017","unstructured":"Che F, Yin J, Quan Y, et al. TLR4 interaction with LPS in glioma CD133+ cancer stem cells induces cell proliferation, resistance to chemotherapy and evasion from cytotoxic T lymphocyte-induced cytolysis. Oncotarget. 2017;8(32):53495-507. https:\/\/doi.org\/10.18632\/oncotarget.18586","journal-title":"Oncotarget."},{"issue":"1","key":"6665_CR23","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1038\/s41568-019-0224-7","volume":"20","author":"JH Sampson","year":"2020","unstructured":"Sampson JH, Gunn MD, Fecci PE, et al. Brain immunology and immunotherapy in brain tumours. Nat Rev Cancer. 2020;20(1):12-25. https:\/\/doi.org\/10.1038\/s41568-019-0224-7","journal-title":"Nat Rev Cancer."},{"issue":"10","key":"6665_CR24","doi-asserted-by":"publisher","first-page":"1647","DOI":"10.1093\/neuonc\/noac055","volume":"24","author":"EC Cordell","year":"2022","unstructured":"Cordell EC, Alghamri MS, Castro MG, et al. T lymphocytes as dynamic regulators of glioma pathobiology. Neuro Oncol. 2022;24(10):1647-57. https:\/\/doi.org\/10.1093\/neuonc\/noac055","journal-title":"Neuro Oncol."},{"issue":"8","key":"6665_CR25","doi-asserted-by":"publisher","first-page":"1096","DOI":"10.1038\/nn.3161","volume":"15","author":"SS Ousman","year":"2012","unstructured":"Ousman SS, Kubes P. Immune surveillance in the central nervous system. Nat Neurosci. 2012;15(8):1096-101. https:\/\/doi.org\/10.1038\/nn.3161","journal-title":"Nat Neurosci."}],"container-title":["Bulletin of Experimental Biology and Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10517-026-06665-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10517-026-06665-2","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10517-026-06665-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,18]],"date-time":"2026-05-18T05:45:16Z","timestamp":1779083116000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10517-026-06665-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2]]},"references-count":25,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2026,2]]}},"alternative-id":["6665"],"URL":"https:\/\/doi.org\/10.1007\/s10517-026-06665-2","relation":{},"ISSN":["0007-4888","1573-8221"],"issn-type":[{"value":"0007-4888","type":"print"},{"value":"1573-8221","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,2]]},"assertion":[{"value":"18 November 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 December 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 April 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}]}}